含不同芳香取代基的肼基二硫代甲酸甲酯-Ga3+配合物的合成及抑菌活性

设计合成了4种含不同芳香取代基团的肼基二硫代甲酸甲酯配体（2-乙酰基吡啶肼基二硫代甲酸甲酯（L¹-H）、2-甲酰基吡啶肼基二硫代甲酸甲酯（L²-H）、2-甲酰基噻吩肼基二硫代甲酸甲酯（L³-H）、2-甲酰基水杨醛肼基二硫代甲酸甲酯（L⁴-H））的镓配合物,对它们的抑菌活性进行了测试,并讨论了配体分子中不同芳香取代基对配合物抑菌活性的影响。在模拟生理条件下,L与Ga³⁺生成较稳定的单核配合物[Ga（L¹）₂]NO₃（1）、[Ga（L²）₂]NO₃（2）、[Ga（L³）₂]NO₃（3）、[Ga（L⁴）₂]NO₃（4）,各配合物对金黄色葡萄球菌和大肠杆菌表现出比Ga（NO₃）₃·9H₂O强的抑制活性,抑制金黄色葡萄球菌的能力高于大肠杆菌,其中,1和2的活性比相应配体高,其余2个配合物与其配体之间无明显活性差异。L¹和L²分子中吡啶基的较强吸电子效应可能是1和2具有较强抑菌活性的主要原因。4种配合物抑制黑曲霉生长的活性同样高于Ga（NO₃）₃·9H₂O,其中3最强,并显著高于L³,其余配合物与相应配体间无活性差异。     

含硫席夫碱安息香缩肼基二硫代甲酸甲酯过渡金属配合物的合成与表征

合成和表征了新的含硫席夫碱—安息香缩肼基二硫代甲酸甲酯 (H2 L)及与Mn(Ⅱ ) ,Co(Ⅱ ) ,Ni(Ⅱ )Zn(Ⅱ )和Cd(Ⅱ )生成的配合物 [M(HL) 2 ]。结果表明这些配合物中安息香缩肼基二硫代甲酸甲酯存在为去质子化的烯硫醇式三齿配体 ,通过甲亚胺基氮原子、醇羟基氧原子和烯硫醇硫原子配位 ,金属离子处于六配位的八面体环境。     

一种新型的肼基硫代酸苄酯希夫碱钌联吡啶配合物的合成

合成了一种新型的肼基硫代酸苄酯希夫碱配体--4-[(N,N-二甲基)氨基]苯甲醛缩肼基硫代甲酸苄酯(L)及其钉(Ru)联吡啶(bpy)配合物[Ru(bpy)2L]PF6(2),其结构经IR,ESI-MS和元素分析表征.研究了2的电子吸收光谱性质.     

含吡咯环的缩氨基硫脲席夫碱镍、铜配合物的晶体结构及与DNA的相互作用（英文）

合成并通过单晶衍射、元素分析及红外光谱表征了配合物[Ni(L1)2]·2DMF(1),[Cu(L1)2]·THF·0.25Me OH·2.25H_2O(2),[Ni(L2)2]·2MeOH(3)和[Cu(L2)2]·2EtOH(4)的结构(HL1:5-甲酰基-3,4-二甲基-吡咯-2-甲酸乙酯缩硫代氨基脲,HL2:5-甲酰基-2,4-二甲基-吡咯-3-甲酸乙酯缩4-异丙基氨基硫脲)。单晶衍射结果表明,除溶剂分子不同外,配合物1~4的结构相似。每个配合物的中心金属离子分别与来自2个阴离子L-配体的N2S2电子供体配位,采取扭曲的平面正方形配位构型。荧光光谱结果表明,配合物与DNA的相互作用强于其配体。     

新型含2,5-二-（3,5-二甲基吡唑-4-巯基）-1,3,4-噻二唑-M(M=Co2+,Cd2+,Mn2+)配合物的合成、晶体结构及其抑菌活性研究

将配体L[2,5-二-(3,5-二甲基吡唑-4-巯基)-1,3,4-噻二唑]与Co(NO3)2 6H2O,Cd(NO3)2 4H2O和MnCl2 4H2O进行配位反应,得到三个配合物[Co(L)2(H2O)4](NO3)2 4(CH3CH2OH)(1),[Cd(L)2(H2O)4](NO3)2 4(CH3CH2OH)(2),[Mn(L)2(Cl)2(CH3OH)2]2(CH3OH)(3),并用元素分析,FT-IR和X射线单晶衍射进行了表征.分析结果表明,配体L呈"U"形,配合物1～3呈"S"形.配合物中Co(II),Cd(II),Mn(II)的配位环境均为扭曲八面体,每个金属离子同时和两个配体进行配位.配体和配合物体外抑菌活性研究结果表明,配体及其配合物都有一定的抑菌活性.     

二齿肼基硫代甲酸苄酯席夫碱锌配合物的合成、晶体结构和抗肿瘤活性

以2,4-二氯苯甲醛缩肼基二硫代甲酸对氯苄酯为配体与锌盐反应合成了配合物Zn(L)2,L=2,4-二氯苯甲醛缩肼基二硫代甲酸对氯苄酯阴离子。通过元素分析和红外光谱对配合物进行了表征,并用X-射线单晶衍射测定了配合物的单晶结构。配合物属于单斜晶系,P21/n空间群,a=1.242 6(10)nm,b=1.024 4(11)nm,c=2.840 2(2)nm,β=101.740 0(10)°,Mr=842.81,V=3.539 7(5)nm3,Z=4,μ=1.412 mm-1,Dc=1.582 g.cm-3,F(000)=1 696,R1=0.039 0,wR2=0.086 2(观察衍射点)和R1=0.164 0,wR2=0.099 6(全部衍射点),Final GooF=1.015。在配合物的晶体结构中,中心锌离子与2个二齿席夫碱配体中的2个硫原子和2个氮原子形成四配位四面体构型。抗肿瘤活性实验采用了MTT比色法,初步研究表明配合物对人胃癌细胞增殖具有明显的抑制作用。     

一种新型的侧链型聚氨酯高分子钌聚合物的合成

通过分子设计,将带有-OH端基的钌(Ⅱ)联吡啶配合物[Ru(bpy)2L]PF6{L=希夫碱4-[(N甲-基-N羟-乙基)氨基]苯甲醛缩肼基硫代甲酸甲酯}与甲苯-2,4异-氰酸酯、丙烯酸羟乙酯发生共聚合反应,合成了新的侧链型聚氨酯高分子钌聚合物(4)。4的结构经红外光谱和差热分析表征。     

双(3-乙氧基水杨醛)缩间苯二甲酰腙四丁(苯)基二锡的合成、结构和荧光性质

在乙醇溶液中以3-乙氧基水杨醛和间苯二甲酰肼反应,制备双(3-乙氧基水杨醛)缩间苯二甲酰腙(H4L)配体.用H4L分别与二丁基氧化锡和三苯基氢氧化锡甲醇溶剂热反应,合成了双(3-乙氧基水杨醛)缩间苯二甲酰腙四丁(苯)基二锡配合物:Bu4Sn2L (T1)和Ph4Sn2L (T2).用元素分析、红外光谱、紫外可见光谱、核...     

钌亚丙二烯基配合物与肼的反应性质:丙烯腈配合物的生成（英文）

以双齿P,N-配体8-(二苯基膦基)喹啉(DPPQ)为支撑配体的钌亚丙二烯基配合物[RuCl(=C=C=CR_2)(DPPQ)_2]-[BPh_4](3a:R=苯基;3b:CR_2=FN=亚芴基)可由双核钌配合物[Ru(μ-Cl)(DPPQ)_2]_2[BPh_4]_2(1)分别与过量的1,1-二苯基炔丙醇(2a)或9-乙炔-9-芴醇(2b)反应得到.配合物3易与肼在室温下反应生成丙烯腈的钌配合物[RuCl(N≡C—CH=CR)2)(DPPQ))2][BPh)4](4a:R=苯基;4b:CR)2=FN=亚芴基),该反应涉及肼对亚丙二烯基配体α-碳原子的分子间亲核进攻,是首例肼对金属亚丙二烯基加成生成丙烯腈的反应.配合物4与过量的丙炔醇2反应可释放出3,3-二苯基丙烯腈(5a)或3-芴基丙烯腈(5b),并再生亚丙二烯基配合物3.此外,初步考察了配合物1对端基炔丙醇与肼反应生成丙烯腈的催化活性,结果表明该催化反应的确可以进行,但是得到的丙烯腈产物的产率不高.尽管结果不是很理想,但是这些研究表明可望发展端基炔丙醇与肼经由过渡金属亚丙二烯基中间体转化为丙烯腈的新催化反应.     

含吩噻嗪锌、镉配合物的双光子激发荧光光谱

报道了两种新型配体(10-乙基-3-甲酰吩噻嗪缩肼基二硫代甲酸甲酯(HL¹)及10-乙基-3-甲酰吩噻嗪缩肼基二硫代甲酸苄酯(HL²))及其锌、镉配合物的双光子(激发)荧光性质. 入射激光强度与荧光强度关系的实验测定证明了发射光为双光子激发荧光. 比较了它们在800和400 nm激发波长下的双光子激发光谱和单光子激发光谱特性. 在800 nm的脉冲激光的激发下, 它们均显示出较强的峰值位于550 ~ 595 nm的双光子激发荧光. 用开孔Z-扫描装置测得它们在1064 nm处均具有较大的双光子吸收截面.     

Chalcone-derived thiosemicarbazones and their zinc(II) and gallium(III) complexes: spectral studies and antimicrobial activity

Chalcone-derived 3-phenyl-1-pyridin-2-ylprop-2-en-1-one thiosemicarbazone (HPyCTPh) (1), 3-(4-chlorophenyl)-1-pyridin-2-ylprop-2-en-1-one thiosemicarbazone (HPyCT4ClPh) (2), 3-(4-bromophenyl)-1-pyridin-2-ylprop-2-en-1-one thiosemicarbazone (HPyCT4BrPh) (3), and 3-(4-nitrophenyl-1-pyridin-2-ylprop-2-en-1-one thiosemicarbazone (HPyCT4NO₂Ph) (4) were obtained as well as their gallium(III) and zinc(II) complexes [Ga(PyCTPh)₂]NO₃ (Ga1), [Ga(PyCT4ClPh)₂]NO₃ (Ga2), [Ga(PyCT4BrPh)₂]NO₃ (Ga3), [Ga(PyCT4NO₂Ph)₂]NO₃ (Ga4), [Zn(PyCTPh)₂] (Zn1), [Zn(PyCT4ClPh)₂] (Zn2), [Zn(PyCT4BrPh)₂] (Zn3), and [Zn(PyCT4NO₂Ph)₂] (Zn4). The chalcones, thiosemicarbazones, and zinc(II) complexes were not active against Pseudomonas aeruginosa. The thiosemicarbazones proved to be more active than the parent chalcones against Staphylococcus aureus and Candida albicans. Coordination to zinc(II) resulted in activity improvement of most thiosemicarbazones against S. aureus. Coordination to gallium(III) significantly improved the antimicrobial activity of all thiosemicarbazones against the studied micro-organisms, suggesting this to be an effective strategy for antimicrobial activity enhancement.     

3-乙基-2-乙酰吡嗪缩N(4)-(对甲苯)氨基硫脲Ga(Ⅲ)、In(Ⅲ)配合物的合成、晶体结构和DNA结合性质

以3-乙基-2-乙酰吡嗪N（4）-（对甲苯）氨基硫脲（HL）为原料,合成了[Ga（L）₂]NO₃·4CH₃OH（1）和[In（L）₂]NO₃·1.75CH₃OH（2）两种新型配合物,并进行了X射线衍射分析表征。结果表明,配合物1和配合物2同构但具有不同数目的结晶甲醇分子。每个配合物的金属中心被2个拥有[N₂S]供体的配体阴离子包围,采取扭曲的八面体配位几何。此外,荧光光谱表明配合物与DNA的相互作用强于配体。     

Well-Defined Aminophenolate Zinc and Magnesium Complexes as Excellent Inhitiators for the ROP of Lactides

A series of molecular homo and heteroleptic zinc and magnesium compounds with aminophenolate ligands [(µ,η²-L²)ZnEt]₂ ( 1 ), [(η²-L²)Zn(µ-BnO)]₂ ( 2 ), [Zn(η²-L²)₂] ( 3 ), [Zn(η²-L³)₂] ( 4 ), [Mg(η²-L³)₂] ( 5 ) (L²-H = N-[methylene(2-hydroxy-3,5-di-tert-butylphenyl)]-N-methyl-N-cyclohexylamine, L³-H = N-[methylene(2-hydroxy-3,5-di-tert-butylphenyl)]-N-methyl-N-methyl-1,3-dioxolaneamine) have been prepared and characterized. The homoleptic complexes 3–5 are most probably a mixture of diastereoisomers that in solution show an interesting dynamics which plays an important role in their catalytic behavior. The complexes 2 – 5 are efficient initiators in ring-opening polymerization (ROP) of lactides to produce polymers with desired molecular weight and narrow polydispersity.     

镉(Ⅱ)、锌(Ⅱ)与2-乙酰吡啶缩邻氨基苯甲酰腙配合物合成及晶体结构

采用Schiff碱配体2-乙酰吡啶缩邻氨基苯甲酰腙(L)分别与Cd(NO₃)₂·4H₂O和Zn(CH₃COO)₂·2H₂O进行配位反应,得到2个配合物[CdL(NO₃)₂·H₂O](1)和[ZnL₂](2).分别采用¹H NMR、FTIR和元素分析等手段对化合物进行了表征,并测定了2个配合物的单晶结构.结构解析表明,配合物1属于单斜晶系,P2₁/n空间群,配合物2属于单斜晶系,P2₁/c空间群.对配体和配合物的体外抑菌活性进行了初步考察,结果表明,配体L和配合物1具有一定的抑菌活性.     

Synthesis,characterization, crystal structure,and DNA-binding of ruthenium(II) complexes of heterocyclic nitrogen ligands resulting from a benzimidazole-based quinazoline derivative

The reaction of cis-[RuCl₂(dmso)₄] with [6-(2-pyridinyl)-5,6-dihydrobenzimidazo[1,2-c]quinazoline] (L) afforded in pure form a blue ruthenium(II) complex, [Ru(L¹)₂] (1), where the original L changed to [2-(1H-benzoimidazol-2-yl)-phenyl]-pyridin-2-ylmethylene-amine (HL¹ ). Treatment of RuCl₃?·?3H₂O with L in dry tetrahydrofuran in inert atmosphere led to a green ruthenium(II) complex, trans-[RuCl₂(L²)₂] (2), where L was oxidized in situ to the neutral species 6-pyridin-yl-benzo[4,5]imidazo[1,2-c]quinazoline (L² ). Complex 2 was also obtained from the reaction of RuCl₃?·?3H₂O with L² in dry ethanol. Complexes 1 and 2 have been characterized by physico-chemical and spectroscopic tools, and 1 has been structurally characterized by single-crystal X-ray crystallography. The electrochemical behavior of the complexes shows the Ru(III)/Ru(II) couple at different potentials with quasi-reversible voltammograms. The interaction of these complexes with calf thymus DNA by using absorption and emission spectral studies allowed determination of the binding constant K _b and the linear Stern–Volmer quenching constant K _SV.     

3,6-二(N-咪唑/苯并咪唑基)哒嗪配体配合物的合成、结构、荧光及光催化性能

用溶剂热法设计、合成了4个金属-有机配合物[Mn(L¹)₄(OH)₂] (1),{[MnL¹(H₂O)₄]SO₄}_n (2),[CdL²(NO₃)₂]_n (3)和{[Co(L²)₂](PF₆)₂}_n (4),(L¹=3,6-二(N-咪唑基)哒嗪,L²=3,6-二(N-苯并咪唑基)哒嗪),并通过元素分析、红外、X射线单晶衍射对配合物结构进行了表征,测试结果表明配合物1具有单核结构,2为一维链结构,配合物3和4均为二维网状结构。此外,对配合物3和4的固态荧光性能及光催化的性能做了进一步研究。     

Ruthenium(II) complexes of aroylhydrazones: structural,electrochemical and electrostatic interactions with DNA

Four Ru(II) complexes with tridentate ligands viz. (4-hydroxy-N′-(pyridin-2-yl-ethylene) benzohydrazide [Ru(L¹)(PPh₃)₂(Cl)] (1), N′-(pyridin-2-yl-methylene) nicotinohydrazide [Ru(L²)(PPh₃)₂(Cl)] (2), N′-(1H-imidazol-2-yl-methylene)-4-hydroxybenzohydrazide [Ru(L³)(PPh₃)₂(Cl)] (3), and N′-(1H-imidazol-2-yl-methylene) nicotinohydrazide [Ru(L⁴)(PPh₃)₂(Cl)] (4) have been synthesized and characterized. The methoxy-derivative of L³H (abbreviated as L³H*) exists in E configuration with torsional angle of 179.4° around C₇-N₈-N₉-C₁₀ linkage. Single crystal structures of acetonitrile coordinated ruthenium complexes of 1 and 3 having compositins as [Ru(L¹)(PPh₃)₂(CH₃CN)]Cl (1a) and [Ru(L³)(PPh₃)₂(CH₃CN)]Cl (3a) revealed coordination of tridentate ligands with significantly distorted octahedral geometry constructed by imine nitrogen, heterocyclic nitrogen, and enolate amide oxygen, forming a cis-planar ring with trans-placement of two PPh₃ groups and a coordinated acetonitrile. Ligands (L¹H-L⁴H) and their ruthenium complexes (1–4) are characterized by ¹H, ¹³C, ³¹P NMR, and IR spectral analysis. Ru(II) complexes have reversible to quasi-reversible redox behavior having Ru(II)/Ru(III) oxidation potentials in the range of 0.40–0.71 V. The DNA binding constants determined by absorption spectral titrations with Herring Sperm DNA (HS-DNA) reveal that L⁴H and 1 interact more strongly than other ligands and Ru(II) complexes. Complexes 1–3 exhibit DNA cleaving activity possibly due to strong electrostatic interactions while 4 displays intercalation.     

Synthesis and spectroscopic characterization of new heteroleptic ruthenium(II) complexes incorporating 2-(2′-pyridyl)quinoxaline and 4-carboxy-2-(2′-pyridyl)quinoline

Starting from cis-[Ru(dcbpyH₂)₂Cl₂] (1), two new heteroleptic ruthenium(II) complexes, [Ru(dcbpyH₂)₂(L¹)](NO₃)₂ (L^1?=?2-(2′-pyridyl)quinoxaline (2), and [Ru(dcbpyH₂)₂(L²)](NO₃)₂ (L^2?=?4-carboxy-2-(2′-pyridyl)quinoline (4); dcbpyH_2?=?2,2′-bipyridine-4,4′-dicarboxylic acid), were synthesized and spectroscopically characterized. During the preparation of 2 and 4, the homoleptic [Ru(dcbpyH₂)₃]Cl₂ complex (3) was isolated as a side product. Characterization includes IR and Raman spectroscopy, UV-Vis, multinuclear NMR spectroscopy, elemental, and ESI-mass spectrometric analyses.     

IR and <Superscript>31</Superscript>P NMR spectroscopic study of complexation of carbamoyl methyl phosphinates with U<Superscript>VI</Superscript> and Th<Superscript>IV</Superscript> in nitric acid solutions

The composition of complexes formed upon the extraction of U^VI and Th^IV nitrates with O-n-nonyl(N,N-dibutylcarbamoylmethyl) methyl phosphinate (L) from solutions of nitric acid without additional solvent was determined by ³¹P NMR spectroscopy. The structures of the complexes formed were studied by IR spectroscopy. Uranium(VI) is extracted from 3 and 5 M solutions of HNO₃ as the [UO₂(L)₂(NO₃)₂] complex, while thorium(IV) is extracted from 5 M HNO₃ as the [Th(L)₃(NO₃)₃]⁺·NO ₃ ⁻ complex. In both cases, ligand L has bidentate coordination. Ligand L contacts with 3 and 5 M nitric acid to form adducts L·HNO₃ and L· (HNO₃)₂, respectively. Published in Russian in Izvestiya Akademii Nauk. Seriya Khimicheskaya, No. 11, pp. 2460–2464, November, 2005.